Prenatal screening after preimplantation genetic testing for aneuploidy: time to evaluate old strategies
Reproductive BioMedicine Online · 2024
DOI: 10.1016/j.rbmo.2023.103761 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproductive BioMedicine Online, 2024. Verfasst von María Gabriela Palacios-Verdú und 7 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Genomic Medicine, Department of Obstetrics, Gynaecology and Reproductive Medicine, Institut Universitari Quirón Dexeus, Barcelona, Spain. Ele…. Hauptthemen laut MEDLINE: Preimplantation Diagnosis, Aneuploidy, Genetic Testing, Fertilization in Vitro. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
RESEARCH QUESTION: How does first-trimester aneuploidy screening perform in pregnancies achieved through IVF with preimplantation genetic testing for aneuploidy (PGT-A) in a medical setting? DESIGN: This retrospective cohort study was undertaken in a single tertiary care centre between January 2013 and June 2022. In total, 20,237 women had prenatal follow-up at the study centre and were included in the study. The women were divided into three groups: singleton pregnancies conceived through the transfer of a PGT-A-screened euploid embryo (n = 510); singleton pregnancies conceived through IVF without PGT-A (n = 3291); and singleton pregnancies conceived naturally (n = 16,436). RESULTS: The conventional combined screening test for pregnancies conceived through IVF with PGT-A had specificity of 91%; sensitivity could not be calculated as there were no cases of fetal aneuploidy in this group. In 89.1% of pregnancies conceived through IVF with PGT-A with high risk for trisomy 21, 18 or 13, the result was related to advanced maternal age (>35 years at time of screening). CONCLUSIONS: The current screening strategy for trisomies 21, 18 and 13 can generate unnecessary tests in pregnancies achieved through IVF with PGT-A. A new protocol is needed for these patients, with greater weight given to ultrasound markers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of Genomic Medicine, Department of Obstetrics, Gynaecology and Reproductive Medicine, Institut Universitari Quirón Dexeus, Barcelona, Spain. Electronic address: gabpal@dexeus.com.
- Obstetrics Service, Department of Obstetrics, Gynaecology and Reproductive Medicine, Institut Universitari Quirón Dexeus, Barcelona, Spain.
- Epidemiological Unit, Department of Obstetrics, Gynaecology and Reproductive Medicine, Institut Universitari Quirón Dexeus, Barcelona, Spain.
- Reproductive Medicine Service, Department of Obstetrics, Gynaecology and Reproductive Medicine, Institut Universitari Quirón Dexeus, Barcelona, Spain.
Zitieren
APA
Palacios-Verdú, M. G., Rodríguez-Melcón, A., Rodríguez, I., Racca, A., Serra, B., Albaiges, G., Parriego, M., & Prats, P. (2024). Prenatal screening after preimplantation genetic testing for aneuploidy: time to evaluate old strategies. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2023.103761
Vancouver
Palacios-Verdú MG, Rodríguez-Melcón A, Rodríguez I, Racca A, Serra B, Albaiges G, et al. Prenatal screening after preimplantation genetic testing for aneuploidy: time to evaluate old strategies. Reproductive BioMedicine Online. 2024. doi:10.1016/j.rbmo.2023.103761
BibTeX
@article{PalaciosVerd2024,
author = {Palacios-Verdú, María Gabriela and Rodríguez-Melcón, Alberto and Rodríguez, Ignacio and Racca, Annalisa and Serra, Bernat and Albaiges, Gerard and Parriego, Mónica and Prats, Pilar},
title = {Prenatal screening after preimplantation genetic testing for aneuploidy: time to evaluate old strategies},
journal = {Reproductive BioMedicine Online},
year = {2024},
doi = {10.1016/j.rbmo.2023.103761}
}
EUVIMED